Somatrogon (Ngenla)

Somatrogon-ghla, tradename Ngenla

Pregnancy category AU: B1

Routes of administration Subcutaneous injection

Somatrogon, sold under the brand name Ngenla, is a medication for the treatment of growth hormone deficiency.

Somatrogon is a glycosylated protein constructed from human growth hormone and a small part of human chorionic gonadotropin which is appended to both the N-terminal and C-terminal.

Once weekly subcutaneous injection.w21w

The most common side effects include reactions at the site of injection, headache, and fever.

Intended for the treatment of growth hormone deficiency in children and adolescents from three years of age.

Leave a Reply

Your email address will not be published. Required fields are marked *